1. Home
  2. PRPO vs RLYB Comparison

PRPO vs RLYB Comparison

Compare PRPO & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precipio Inc.

PRPO

Precipio Inc.

HOLD

Current Price

$26.86

Market Cap

44.4M

Sector

Industrials

ML Signal

HOLD

Logo Rallybio Corporation

RLYB

Rallybio Corporation

HOLD

Current Price

$9.50

Market Cap

28.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRPO
RLYB
Founded
N/A
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
44.4M
28.7M
IPO Year
2000
2021

Fundamental Metrics

Financial Performance
Metric
PRPO
RLYB
Price
$26.86
$9.50
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
N/A
AVG Volume (30 Days)
8.4K
243.5K
Earning Date
05-27-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
35.03
27.72
EPS
N/A
N/A
Revenue
$18,532,000.00
$600,000.00
Revenue This Year
N/A
$17.61
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
21.95
N/A
52 Week Low
$4.90
$0.22
52 Week High
$29.53
$11.49

Technical Indicators

Market Signals
Indicator
PRPO
RLYB
Relative Strength Index (RSI) 58.27 71.26
Support Level $22.58 $0.48
Resistance Level $28.38 $11.49
Average True Range (ATR) 1.52 0.89
MACD 0.33 -0.09
Stochastic Oscillator 66.14 68.17

Price Performance

Historical Comparison
PRPO
RLYB

About PRPO Precipio Inc.

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

About RLYB Rallybio Corporation

Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.

Share on Social Networks: